Why clinical trials are rarely conducted in Sub-saharan Africa

Out of 48 low-income countries and the least developed countries analysed by the foundation, 32 are in Africa.[Photo, courtesy]

Patients in low and middle-income countries (LMICs) are largely excluded from clinical trials by pharmaceutical companies, limiting their access to life-saving treatments and therapies.

An Access to Medicine Foundation report reveals that pharmaceutical companies tend to conduct trials in countries where they plan to market their products, often neglecting sub-Saharan African countries.